S U M M A R Y Hypothalamic-pituitary function tests have been carried out in young, obese females with both recently diagnosed and longstanding benign intracranial hypertension. No abnormalities have been found which could be implicated in the pathogenesis of the condition, nor have we been able to demonstrate any convincing evidence of long-term hypothalamic pituitary damage. The results of these investigations can be difficult to interpret and invalid conclusions may be drawn if all factors involved are not carefully considered.
The syndrome of benign intracranial hypertension is thought to be due to brain swelling,' but the underlying pathogenic mechanisms are still poorly understood. An endocrine disturbance has been inferred since the condition is found typically in young obese women, often with menstrual irregularities or taking an oral contraceptive pill, in patients with Addison's disease,2 during reduction of corticosteroid therapy,4 5 and in treatment of hyperadrenal states.6 In a recent report it has been claimed that hypothalamic-hypophyseal insufficiency may result from the condition.7 Tests of anterior pituitary function have been performed on patients with the disease for both short and prolonged periods, to determine their value in elucidating any underlying disturbance or as prognostic aids.
Patients and methods
Patients with "acute" and "chronic" benign intracranial hypertension Five obese female patients with active benign intracranial hypertension which had been diagnosed within the last three months were studied. In three patients the test was conducted prior to commencement of treatment, and the other two were being treated with acetazolamide and lumbar punctures. Tests were also carried out in another five obese female patients in whom the length of time since diagnosis ranged from 14 months to 13 years (mean 7 years 2 months). At the time of the study the disease was still active as the patients had persisting papilloedema and raised intracranial pressure. Current treatment was analgesics alone (two) and acetazolamide (two). One patient had a non-functioning ventriculoperitoneal shunt. None of the patients had received corticosteroids in the preceding two years.
Control subjects
There were 10 similarly age-matched obese young women who had been investigated at the Royal Infirmary, Glasgow, for amenorrhoea or for suspected Cushing's syndrome. In all patients a diagnosis of simple dietary obesity had been made after exclusion of any endocrine disease.
Methods
Anterior pituitary function was assessed in response to insulin-induced hypoglycaemia (0-2 units soluble insulin per kg), thyrotropin releasing hormone (200,ug) and gonadotropin releasing hormone (100 ,ug) after an overnight fast. In each patient symptomatic hypoglycaemia was produced and the blood sugar level fell well below 2-0 mmol/l. Blood samples were taken for blood sugar, cortisol, growth hormone, TSH, FSH, LH and prolactin levels at 0, 30, 60, 90, and 120 minutes from an indwelling venous catheter. Hormone assays were performed in the Radioimmuno- is of interest to note that one patient with "acute" benign intracranial hypertension had a borderline growth hormone response and one control subject had an abnormal response, suggesting that obesity may have been the important common factor.
The care with which tests are performed is another important factor for consideration. Barber and Garvan7 claimed that five out of their eight patients with benign intracranial hypertension had inadequate cortisol responses to insulin-induced hypo glycaemia. Examination of the data, however, showed that the "basal" cortisol and growth hormone levels were high, suggesting that their patients were stressed prior to commencement of the test. It is also invalid to perform these tests on patients who have been treated with corticosteroids in the preceding months as a degree of adrenal suppression may still be present.
The 
